Evidence map›Paper›PMID 39375246›Full record

ReviewDiscover nano2024

Natural hydroxyapatite-based nanobiocomposites and their biomaterials-to-cell interaction for bone tissue engineering.

Jayachandran Venkatesan, Rowena Valeen Anchan, Sesha Subramanian Murugan, Sukumaran Anil, Se-Kwon Kim

Abstract readReview
In one paragraph

Review in Discover nano, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jayachandran VenkatesanBiomaterials Research Laboratory, Yenepoya Research Centre, Yenepoya (Deemed to Be University), Deralakatte, Mangaluru, 575018, India.
Rowena Valeen AnchanBiomaterials Research Laboratory, Yenepoya Research Centre, Yenepoya (Deemed to Be University), Deralakatte, Mangaluru, 575018, India.
Sesha Subramanian MuruganBiomaterials Research Laboratory, Yenepoya Research Centre, Yenepoya (Deemed to Be University), Deralakatte, Mangaluru, 575018, India.
Sukumaran AnilOral Health Institute, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.
Se-Kwon KimDepartment of Marine Science & Convergence Engineering, College of Science & Technology, Hanyang University ERICA Campus, Ansan, 11558, Republic of Korea. sknkim@pknu.ac.kr.

Funding

Yenepoya University YU/Seed Grant/153-2024
6 · The paper itself

Abstract

Hydroxyapatite (HA) is an extensively used biomaterial for dental and orthopaedic applications because of its biocompatibility and biomimetic nature. HA is extensively used as a bone-graft substitute. HA bone graft substitutes of bovine or synthetic origins have been extensively studied. However, caprine-based HA has not been explored. In this study, we aimed to determine the utilization of goat bone-derived HA for commercial applications. HA from caprine bone and teeth was isolated using thermal calcination. The developed HA can be used as a bone graft substitute. Chemical characterization of the isolated HA was carried out using Fourier transform infrared spectroscopy, X-Ray Diffraction, Raman spectroscopy, scanning electron microscopy, and transmission electron microscopy. The biocompatibility and apatite formation of isolated HA were assessed using MG-63 cells, MC3T3-E1, L929 cells, MSCs, adipose derived stem cells, human dermal tissue derived fibroblast cells and osteoblast-like cell line, The studies demonstrate that HA support cell adhesion and osteogenic properties. To improve sheep, lamp, or caprine bone-derived HA, several other composites have been developed with MgO

Indexed as

Bone-graft substituteCaprine boneGoat boneSheep boneThermal calcination

Identifiers

PMID39375246
PMCPMC11458869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.